Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ricardo Gómez-Huelgas and Luis Pérez-Belmonte.
Ricardo Gómez-Huelgas
Connection Strength
1.431
Luis Pérez-Belmonte
  1. Differences between Clinical Protocols for the Treatment of Coronavirus Disease 2019 (COVID-19) in Andalusia, Spain. Int J Environ Res Public Health. 2020 09 19; 17(18).
    View in: PubMed
    Score: 0.904
  2. Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study. BMC Med. 2020 11 16; 18(1):359.
    View in: PubMed
    Score: 0.228
  3. Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry. Ann Med. 2021 12; 53(1):103-116.
    View in: PubMed
    Score: 0.061
  4. [Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain]. Rev Clin Esp. 2021 Jul 17.
    View in: PubMed
    Score: 0.060
  5. Cardiometabolic Therapy and Mortality in Very Old Patients With Diabetes Hospitalized due to COVID-19. J Gerontol A Biol Sci Med Sci. 2021 07 13; 76(8):e102-e109.
    View in: PubMed
    Score: 0.060
  6. Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study. Nutrients. 2021 May 21; 13(6).
    View in: PubMed
    Score: 0.059
  7. Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry. Drugs. 2021 Apr; 81(6):685-695.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.